Structural Determinants of p53-Independence in Anticancer Ruthenium-Arene Schiff-Base Complexes

Mun Juinn Chow1,2, Maria V Babak1, Daniel Yuan Qiang Wong1

  • 1Department of Chemistry, National University of Singapore , 3 Science Drive 3, 117543 Singapore.

Insights

Researchers discovered novel ruthenium (II)-arene Schiff-base (RAS) complexes that kill cancer cells independently of the p53 gene. These new anticancer drugs overcome resistance, offering a promising alternative to p53-dependent therapies.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • The p53 tumor suppressor gene is crucial for cellular processes and cancer therapy.
  • In over 50% of cancers, p53 is inactivated, leading to drug resistance and poor outcomes with p53-dependent drugs.
  • There is a need for anticancer drugs with a p53-independent mechanism of action to overcome therapy resistance.

Purpose of the Study:

  • To identify novel anticancer agents with p53-independent activity.
  • To investigate the structural features of ruthenium (II)-arene Schiff-base (RAS) complexes responsible for p53-independent cytotoxicity.
  • To explore the relationship between physicochemical properties, cellular accumulation, and efficacy of these complexes.

Main Methods:

  • Synthesis and characterization of nine Ru (II)-Arene Schiff-base (RAS) complexes.
  • Evaluation of cytotoxicity in cancer cell lines.
  • Assessment of p53-dependency of the cytotoxic effect.
  • Analysis of structure-activity relationships, including hydrophobicity and ligand effects.

Main Results:

  • Nine RAS complexes were identified that induce significant p53-independent cytotoxicity.
  • Increased hydrophobicity correlated with enhanced cellular accumulation and improved efficacy.
  • All nine complexes exhibited p53-independent activity, irrespective of variations in physicochemical properties.
  • The iminoquinoline ligand was identified as a key structural feature for p53-independent activity.

Conclusions:

  • Ruthenium (II)-arene Schiff-base (RAS) complexes represent a promising class of anticancer agents with a p53-independent mode of action.
  • Hydrophobicity and the presence of an iminoquinoline ligand are critical for the efficacy and cellular uptake of these novel compounds.
  • These findings offer a potential strategy to circumvent p53-mediated drug resistance in cancer therapy.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Radical Reactivity: Steric Effects01:10

Radical Reactivity: Steric Effects

The presence of electron-donating, electron-withdrawing, or conjugating groups adjacent to a radical center, imparts electronic stabilization to the radicals. Examples of such electronically-stabilized radicals are triphenylmethyl, tetramethylpiperidine‐N‐oxide, and 2,2‐diphenyl‐1‐picrylhydrazyl. These radicals are remarkably stable and are known as persistent radicals. Some of the persistent radicals can even be isolated and purified.
Along with electronic...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K